{
  "id": "53442472aeec6fbd07000008",
  "type": "summary",
  "question": "Do ephrins play a role in brain cancer?",
  "ideal_answer": "Eph receptors and ephrin ligands are involved in the development of the central nervous system. Their expression is often reported to be up-regulated in brain tumours and they may be considered molecular markers for the diagnosis of invasive and metastatic tumours. However, there are also reports describing the down-regulation of the Eph/ephrin family in brain cancer.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/18794797",
    "http://www.ncbi.nlm.nih.gov/pubmed/16254188",
    "http://www.ncbi.nlm.nih.gov/pubmed/23686814",
    "http://www.ncbi.nlm.nih.gov/pubmed/18366728",
    "http://www.ncbi.nlm.nih.gov/pubmed/15126357",
    "http://www.ncbi.nlm.nih.gov/pubmed/15473927",
    "http://www.ncbi.nlm.nih.gov/pubmed/19728339",
    "http://www.ncbi.nlm.nih.gov/pubmed/16951161",
    "http://www.ncbi.nlm.nih.gov/pubmed/20571968",
    "http://www.ncbi.nlm.nih.gov/pubmed/19270726",
    "http://www.ncbi.nlm.nih.gov/pubmed/22723427",
    "http://www.ncbi.nlm.nih.gov/pubmed/19074825",
    "http://www.ncbi.nlm.nih.gov/pubmed/22688511",
    "http://www.ncbi.nlm.nih.gov/pubmed/14726470",
    "http://www.ncbi.nlm.nih.gov/pubmed/10984508",
    "http://www.ncbi.nlm.nih.gov/pubmed/18089715",
    "http://www.ncbi.nlm.nih.gov/pubmed/22374425",
    "http://www.ncbi.nlm.nih.gov/pubmed/17332925"
  ],
  "snippets": [
    {
      "text": "migrating glioblastoma cells overexpress EphB2 in vitro and in vivo; glioma migration and invasion are promoted by activation of EphB2 or inhibited by blocking EphB2. Dysregulation of EphB2 expression or function may underlie glioma invasion",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15126357",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "gene expression of Eph receptors and ephrins in benign human tissues and cancers",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/14726470",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "EphA1/EphA8 was down-regulated in glioblastomas",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/14726470",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/10984508",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "high-level expressions of favorable NB genes, such as EPHB6, can in fact suppress malignant phenotype of unfavorable NB",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/10984508",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "phrin-As, Eph receptors and integrin \u03b13 interact and colocalise at membrane protrusions of U251MG glioblastoma cells",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23686814",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "crosstalk between Eph and integrin signalling pathways at the membrane protrusions and in the migration of brain cancer cells",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23686814",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "phB2 activity plays a pivotal role in pediatric medulloblastoma cell adhesion and invasion",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22723427",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "deregulation of Eph/ephrin expression in medulloblastoma enhances the invasive phenotype, suggesting a potential role in local tumor cell invasion and the formation of metastases",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22723427",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "phrinA1 is released in three forms from cancer cells",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22688511",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "phrinA1 is a glycosylphosphatidylinositol (GPI)-linked ligand for the EphA2 receptor, which is overexpressed in glioblastoma (GBM), among other cancers",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22688511",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "EphrinB2 and EphB4 in glioma tissues correlated to the progression of glioma and the prognosis of glioblastoma patients",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22374425",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "EphrinB2 and EphB4 expressions increase according to the histopathological grade and KPS score of glioma, and their expression levels are related to the progression-free survival of glioblastoma patients",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22374425",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "p-regulation of EphA2 and down-regulation of EphrinA1 are associated with the aggressive phenotype and poor prognosis of malignant glioma",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20571968",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "gliomas display over-expression of the receptor tyrosine kinase EphA2. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20571968",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "phosphorylation of ephrin-B2 ligand promotes glioma cell migration and invasion",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19728339",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "high expression of ephrin-B2 is a strong predictor of short-term survival and that ephrin-B2 plays a critical role in glioma invasion rendering this signaling pathway as a potential therapeutic target",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19728339",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "phrinA5 acts as a tumor suppressor in glioma",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19270726",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "expression of ephrinA5 was dramatically downregulated in primary gliomas compared with normal tissues",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19270726",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "EphA2 receptor and ephrinA1 ligand in solid tumors",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19074825",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "investigating the ephrinA1/EphA2 system in the pathobiology of glioblastoma multiforme (GBM), we uncovered that ephrinA1 is released from GBM and breast adenocarcinoma cells as a soluble",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18794797",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "ccumulating evidence indicates that Eph and ephrins are frequently overexpressed in different tumor types including GBM",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18366728",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "EphA2 receptor tyrosine kinase is overexpressed in glioblastoma multiforme (GBM) and represents a novel, attractive therapeutic target for the treatment of brain tumor",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18089715",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "phrin-A1 is a negative regulator in glioma",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17332925",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": " ephrin-A1 serves as a critical negative regulator in the tumorigenesis of gliomas",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17332925",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "overexpression of EphB2 in glioma cells increases cell invasion",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16951161",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "phA2 as a novel molecular marker and target in glioblastoma multiforme",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16254188",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "EphA2 is both specifically overexpressed in GBM and expressed differentially with respect to its ligand, ephrinA1",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16254188",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "EphB4 and EphrinB2 protein expression in astrocytomas",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15473927",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Expressions of EphB4 and EphrinB2 proteins may be related to differentiation degree of tumor cells",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15473927",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [
    "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D036342",
    "http://www.disease-ontology.org/api/metadata/DOID:162",
    "http://www.disease-ontology.org/api/metadata/DOID:1319",
    "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D001932",
    "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0046875"
  ]
}